Cranberry Peak is a leading company in the AI industry, and recently announced a partnership with Ambra Health. Cranberry Peak’s ezCDS is offered to Ambra Health’s client base, to help implement the Appropriate Use Criteria Program. ezCDS is a clinical decision support mechanism designed for the Appropriate Use Criteria Program, and supports the implementation of PAMA.

More specifically, physicians will need to consult ezCDS before ordering an advanced diagnostic imaging service. A concern about the increasing costs of healthcare, and one of the main concerns of physicians’ dissatisfaction starts with the administrative burden. The ezCDS system makes compliance easy, and provides an outstanding user experience.

Neculai Archip, Founder and CEO of Cranberry Peak, said, “In a time when there is so much talk about AI, providers of care still spend hours every day with their computer screens. Our goal is to fix this, and to help them spend more time with patients… This is what ezCDS helps you do, with an entirely new approach to user experience. We are changing the way healthcare professionals interact with their software and helping the transition to value based care with our evidence based medicine solution.”

Read more at PR Web.